Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection-Reference-Cited by-同舟云学术

Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection

Published:2020-11 Issue:11 Volume:22 Page:1898-1902
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Beitelshees Amber L.^ORCID,Stevenson James M.,El Rouby Nihal,Dillon Chrisly,Empey Philip E.,Fielstein Elliot M.,Johnson Julie A.,Limdi Nita A.,Ong Henry H.,Franchi Francesco,Angiolillo Dominick J.,Peterson Joshua F.,Rosenman Marc B.,Skaar Todd C.,Tuteja Sony,Cavallari Larisa H.

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/s41436-020-0894-2.pdf

Reference18 articles.

1. Multisite investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy;Empey;Clin Pharmacol Ther,2018

2. Limdi NA, Cavallari LH, Lee CR, et al. Cost-effectiveness ofCYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome andpercutaneous coronary intervention informed by real world data. PharmacogenomicsJ. 2020 Feb 11; https://doi.org/10.1038/s41397-020-0162-5 [Epub ahead of print].

3. Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel;Reese;Pharmacotherapy,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results;Genetics in Medicine;2024-04

2. Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program;American Journal of Health-System Pharmacy;2024-01-22

3. Clinician Response to Pharmacogenetic Clinical Decision Support Alerts;Clinical Pharmacology & Therapeutics;2023-11-02

4. Use of the Electronic Health Record for Monitoring Adverse Drug Reactions;Current Allergy and Asthma Reports;2023-05-16

5. Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives;Expert Opinion on Drug Metabolism & Toxicology;2022-12-02